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We read with interest the work of Chaitanyanand Koppiker
and colleagues [1] and would like to add some useful
suggestions to improve oncological and cosmetic outcomes.
Extreme oncoplastic surgery (EOS) is a breast conserving
operation, using oncoplastic techniques, in a patient who
requires a mastectomy. It is a promising new concept in
the multidisciplinary treatment of selected patients with
generally large, greater than 5 cm multifocal or multicentric
tumor desiring breast conservation [2–4].
These oncoplastic techniques allow the resection of a
greater amount of breast tissue with safer margins and
acceptable aesthetic results increasing breast conservation
rates [5–8].
The indications for EOS are different and various algo-
rithms have been devised to assist with the decision process
[3–5]. Long-term data on recurrence and survival are not
available, using this approach. It is expected that the local
recurrencewill be somewhat higher but that therewill be little
or no impact on survival [3, 9].
Chaitanyanand Koppiker and colleagues conclude in
their study that “ExtremeOncoplastic Surgery followedbyRT
results in acceptable local-regional control, low rate of com-
plications, and high patient satisfaction. In selected patients,
EO could provide a safe alternative for breast conservation
surgery instead of mastectomy” [1].
However, a “great surgical hand” in EOS is not enough to
optimize the oncological and aesthetic results! We think that
a good oncoplastic surgery requires both individual ability
and technical skill but also other attributes as dedication,
decision-making skills, and the repetitive performance of
specific tasks.
So, while performing the extreme oncoplastic breast
conserving surgery, the modern oncoplastic surgeon should
always follow some specific and crucial steps, such as careful
local staging of the disease with ultrasonography, mammog-
raphy, andmagnetic resonance before surgery; adequate radi-
ological preoperative study with localization of tumor and/or
calcifications; multidisciplinary discussion, in a dedicated
“surgery board”, to choose an oncoplastic technique tailored
to patient; intraoperative ultrasound to guide the resection;
intraoperative radiological and pathological evaluation of the
specimen for definition of lesion and margins of resection;
frozen sections should be obtained from a portion of all six
faces of the resected specimen; systematic circumferential
tumor cavity shaving to have a backup to lumpectomy
margins; placement of clips within the excision cavity as
a “landmark” to define the tumor bed and guide adjuvant
breast radiotherapy; accurate pathological assessment of the
specimen using macrosections.
This multidisciplinary path leads more easily to tumor-
free margins by keeping the amount of healthy breast tissue
excision as low as possible; while performing oncoplastic pro-
cedures, it would be useful to bear in mind these recommen-
dations and suggestions in order to improve oncological and
cosmetic outcomes. The modern breast surgeon must always
know where they are going and the repetitive performance of
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specific tasks could enhance their ability when faced with the
extreme and complex oncoplastic procedures.
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